At-home wearables and machine learning sensitively capture disease progression in amyotrophic lateral sclerosis

• Published in: Nature communications Vol. 14; no. 1; p. 5080
• Main Authors: Gupta, Anoopum S, Patel, Siddharth, Premasiri, Alan, Vieira, Fernando
• Format: Journal Article
• Language: English
• Published: England Nature Publishing Group 21.08.2023; Nature Publishing Group UK; Nature Portfolio
• Subjects: Accelerometers; Amyotrophic lateral sclerosis; Amyotrophic Lateral Sclerosis - diagnosis; Clinical trials; Degeneration; Disease Progression; Drug development; Humans; Machine Learning; Motor Neurons; Wearable Electronic Devices; Wearable technology
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-023-40917-3

Amyotrophic lateral sclerosis causes degeneration of motor neurons, resulting in progressive muscle weakness and impairment in motor function. Promising drug development efforts have accelerated in amyotrophic lateral sclerosis, but are constrained by a lack of objective, sensitive, and accessible outcome measures. Here we investigate the use of wearable sensors, worn on four limbs at home during natural behavior, to quantify motor function and disease progression in 376 individuals with amyotrophic lateral sclerosis. We use an analysis approach that automatically detects and characterizes submovements from passively collected accelerometer data and produces a machine-learned severity score for each limb that is independent of clinical ratings. We show that this approach produces scores that progress faster than the gold standard Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (-0.86 ± 0.70 SD/year versus -0.73 ± 0.74 SD/year), resulting in smaller clinical trial sample size estimates (N = 76 versus N = 121). This method offers an ecologically valid and scalable measure for potential use in amyotrophic lateral sclerosis trials and clinical care.